Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 1630

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 9
Chunk 1630
---
 at www.channeltherapeutics.com.

Audit
Committee

Our
audit committee is composed of Ezra Friedberg and Chia-Lin Simmons. Ezra Friedberg is the chairperson of our audit committee.
The composition of our audit committee meets the requirements for independence under the current NYSE American listing standards
and SEC rules and regulations. Each member of our audit committee is financially literate. In addition, our board of directors
has determined that Ezra Friedberg is an “audit committee financial expert” as defined in Item 407(d)(5)(ii) of Regulation
S-K promulgated under the Securities Act. This designation does not impose any duties, obligations or liabilities that are greater
than are generally imposed on members of our audit committee and our board of directors. Our audit committee is responsible for,
among other things:

    ●
    our accounting and
    financial reporting processes, including our financial statement audits and the integrity of our consolidated financial statements;

    ●
    our compliance with
    legal and regulatory requirements;

    ●
    reviewing and approving
    related person transactions;

    ●
    selecting and hiring
    our registered independent public accounting firm; 

    ●
    the qualifications,
    independence and performance of our independent auditors; and

    ●
    the preparation
    of the audit committee report to be included in our annual proxy statement.

Compensation
Committee

Our
compensation committee is composed of Richard Malamut and Chia-Lin Simmons. Richard Malamut is the chairperson of our compensation
committee. The composition of our compensation committee meets the requirements for independence under the current NYSE American
listing standards and SEC rules and regulations. Each member of this committee is: (i) an outside director, as defined pursuant
to Section 162(m) of the Internal Revenue Code of 1986, as amended; and (ii) a non-employee director, as defined in Rule 16b-3
promulgated under the Exchange Act. Our compensation committee is responsible for, among other things:

    ●
    evaluating, recommending,
    approving and reviewing executive officer and director compensation arrangements, plans, policies and programs;

    ●
    administering our
    cash-based and equity-based compensation plans; and

    ●
    making recommendations
    to our board of directors regarding any other board of director responsibilities relating to executive compensation.

87 

Nominating
and Corporate Governance Committee

Our
nominating and corporate governance committee is composed of